Modern Anti-Myeloma Therapies and Outcomes of Patients With Primary Plasma Cell Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group
Am. J. Hematol 2023 Mar 04;[EPub Ahead of Print], E Katodritou, E Kastritis, D Dalampira, S Delimpasi, E Spanoudakis, V Labropoulou, I Ntanasis-Stathopoulos, AI Gkioka, N Giannakoulas, N Kanellias, T Papadopoulou, A Sevastoudi, E Michalis, M Papathanasiou, M Kotsopoulou, A Sioni, T Triantafyllou, A Daiou, M Papadatou, MC Kyrtsonis, A Pouli, I Kostopoulos, E Verrou, MA Dimopoulos, E TerposFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.